Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 15;16(11):1615.
doi: 10.3390/ph16111615.

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Affiliations
Review

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Ghazala Muteeb et al. Pharmaceuticals (Basel). .

Abstract

Antibiotics have revolutionized medicine, saving countless lives since their discovery in the early 20th century. However, the origin of antibiotics is now overshadowed by the alarming rise in antibiotic resistance. This global crisis stems from the relentless adaptability of microorganisms, driven by misuse and overuse of antibiotics. This article explores the origin of antibiotics and the subsequent emergence of antibiotic resistance. It delves into the mechanisms employed by bacteria to develop resistance, highlighting the dire consequences of drug resistance, including compromised patient care, increased mortality rates, and escalating healthcare costs. The article elucidates the latest strategies against drug-resistant microorganisms, encompassing innovative approaches such as phage therapy, CRISPR-Cas9 technology, and the exploration of natural compounds. Moreover, it examines the profound impact of antibiotic resistance on drug development, rendering the pursuit of new antibiotics economically challenging. The limitations and challenges in developing novel antibiotics are discussed, along with hurdles in the regulatory process that hinder progress in this critical field. Proposals for modifying the regulatory process to facilitate antibiotic development are presented. The withdrawal of major pharmaceutical firms from antibiotic research is examined, along with potential strategies to re-engage their interest. The article also outlines initiatives to overcome economic challenges and incentivize antibiotic development, emphasizing international collaborations and partnerships. Finally, the article sheds light on government-led initiatives against antibiotic resistance, with a specific focus on the Middle East. It discusses the proactive measures taken by governments in the region, such as Saudi Arabia and the United Arab Emirates, to combat this global threat. In the face of antibiotic resistance, a multifaceted approach is imperative. This article provides valuable insights into the complex landscape of antibiotic development, regulatory challenges, and collaborative efforts required to ensure a future where antibiotics remain effective tools in safeguarding public health.

Keywords: antibiotic resistance; bacterial evolution; bacterial mutation; drug designing; horizontal gene transfer; public and agricultural health.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Different pathways of antibiotic resistance as antibiotic enters into the cell of bacteria or microorganisms.
Figure 2
Figure 2
Differentiating the antibiotic action and antibiotic resistance through different aspects within a bacterial cell.
Figure 3
Figure 3
Impact and adverse effect of antibiotic resistance on health, wildlife, and environment.
Figure 4
Figure 4
Solutions to address the economic barriers in antibiotic research and development.

Similar articles

Cited by

References

    1. World Health Organization (WHO) Priority Medicines for Europe and the World/Warren Kaplan, Richard Laing 2004. [(accessed on 25 August 2023)]. Available online: https://iris.who.int/handle/10665/68769?show=full.
    1. Rehman M.T., Faheem M., Khan A.U. An insight into the biophysical characterization of different states of cefotaxime hydrolyzing β-lactamase 15 (CTX-M-15) J. Biomol. Struct. Dyn. 2015;33:625–638. doi: 10.1080/07391102.2014.899925. - DOI - PubMed
    1. Livermore D.M. Bacterial Resistance: Origins, Epidemiology, and Impact. Clin. Infect. Dis. 2003;36:S11–S23. doi: 10.1086/344654. - DOI - PubMed
    1. Muteeb G., Alsultan A., Farhan M., Aatif M. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Molecules. 2022;27:1283. doi: 10.3390/molecules27041283. - DOI - PMC - PubMed
    1. Khan A.U., Rehman M.T. Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1. Antimicrob. Agents Chemother. 2016;60:356–360. doi: 10.1128/AAC.01194-15. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources